Fort, L.P. Eli Lilly & CO Transaction History

Fort, L.P.

$38.5 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $140,624 - $176,353	-194 Reduced 38.04%	316 $286,000
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $220,298 - $294,728	-372 Reduced 42.18%	510 $396,000
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $14,345 - $19,776	-33 Reduced 3.61%	882 $473,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $32,268 - $43,146	-92 Reduced 9.14%	915 $429,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $25,161 - $29,550	-81 Reduced 7.44%	1,007 $345,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $58,843 - $68,564	183 Added 20.22%	1,088 $398,000
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $32,612 - $37,165	-110 Reduced 10.84%	905 $293,000
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $282,910 - $332,179	1,015 New	1,015 $329,000
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $249,944 - $310,617	-1,065 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $736,383 - $913,856	-3,275 Reduced 75.46%	1,065 $294,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $546,244 - $672,230	-2,465 Reduced 36.22%	4,340 $1 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $607,731 - $786,095	-3,366 Reduced 33.09%	6,805 $1.56 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $63,098 - $81,684	-384 Reduced 3.64%	10,171 $1.9 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $275,531 - $364,594	2,112 Added 25.01%	10,555 $1.78 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $90,656 - $104,860	620 Added 7.93%	8,443 $1.25 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $1.96 Million - $2.35 Million	-14,337 Reduced 64.7%	7,823 $1.28 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $104,049 - $128,783	-874 Reduced 3.79%	22,160 $3.07 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $78,265 - $96,938	732 Added 3.28%	23,034 $3.03 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $118,643 - $129,053	-1,111 Reduced 4.75%	22,302 $2.49 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $279,633 - $326,403	2,524 Added 12.08%	23,413 $2.59 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $577,587 - $679,862	5,189 Added 33.05%	20,889 $2.71 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $714,930 - $800,938	6,751 Added 75.44%	15,700 $1.82 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $646,869 - $808,473	7,534 Added 532.44%	8,949 $960,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $107,115 - $122,935	1,415 New	1,415 $121,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.7 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.3 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.5 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.4 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.

Account